Logo image of KRN.CA

KARNALYTE RESOURCES INC (KRN.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:KRN - CA4856722083 - Common Stock

0.26 CAD
-0.01 (-3.7%)
Last: 1/13/2026, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KRN. KRN was compared to 29 industry peers in the Chemicals industry. KRN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KRN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • KRN had negative earnings in the past year.
  • In the past year KRN has reported a negative cash flow from operations.
  • KRN had negative earnings in each of the past 5 years.
  • In the past 5 years KRN always reported negative operating cash flow.
KRN.CA Yearly Net Income VS EBIT VS OCF VS FCFKRN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • The Return On Assets of KRN (-16.19%) is comparable to the rest of the industry.
  • KRN's Return On Equity of -25.22% is in line compared to the rest of the industry. KRN outperforms 44.83% of its industry peers.
Industry RankSector Rank
ROA -16.19%
ROE -25.22%
ROIC N/A
ROA(3y)-19.94%
ROA(5y)-23.31%
ROE(3y)-27.54%
ROE(5y)-32.76%
ROIC(3y)N/A
ROIC(5y)N/A
KRN.CA Yearly ROA, ROE, ROICKRN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRN.CA Yearly Profit, Operating, Gross MarginsKRN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, KRN has about the same amount of shares outstanding.
  • KRN has more shares outstanding than it did 5 years ago.
  • KRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KRN.CA Yearly Shares OutstandingKRN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
KRN.CA Yearly Total Debt VS Total AssetsKRN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • KRN has an Altman-Z score of -28.35. This is a bad value and indicates that KRN is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -28.35, KRN is doing worse than 75.86% of the companies in the same industry.
  • There is no outstanding debt for KRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -28.35
ROIC/WACCN/A
WACCN/A
KRN.CA Yearly LT Debt VS Equity VS FCFKRN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that KRN should not have too much problems paying its short term obligations.
  • KRN's Current ratio of 1.58 is in line compared to the rest of the industry. KRN outperforms 51.72% of its industry peers.
  • KRN has a Quick Ratio of 1.58. This is a normal value and indicates that KRN is financially healthy and should not expect problems in meeting its short term obligations.
  • KRN has a Quick ratio of 1.58. This is in the better half of the industry: KRN outperforms 79.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
KRN.CA Yearly Current Assets VS Current LiabilitesKRN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.80% over the past year.
EPS 1Y (TTM)38.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • KRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRN.CA Price Earnings VS Forward Price EarningsKRN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRN.CA Per share dataKRN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • KRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

KARNALYTE RESOURCES INC

TSX:KRN (1/13/2026, 7:00:00 PM)

0.26

-0.01 (-3.7%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07
Earnings (Next)05-06
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.85M
Revenue(TTM)N/A
Net Income(TTM)-1.02M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.43
P/tB 3.43
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.19%
ROE -25.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.94%
ROA(5y)-23.31%
ROE(3y)-27.54%
ROE(5y)-32.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6615.38%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z -28.35
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)6983.33%
Cap/Depr(5y)4698%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.26%
OCF growth 3YN/A
OCF growth 5YN/A

KARNALYTE RESOURCES INC / KRN.CA FAQ

What is the ChartMill fundamental rating of KARNALYTE RESOURCES INC (KRN.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to KRN.CA.


What is the valuation status for KRN stock?

ChartMill assigns a valuation rating of 0 / 10 to KARNALYTE RESOURCES INC (KRN.CA). This can be considered as Overvalued.


What is the profitability of KRN stock?

KARNALYTE RESOURCES INC (KRN.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for KRN stock?

The financial health rating of KARNALYTE RESOURCES INC (KRN.CA) is 5 / 10.